A critical appraisal and clinical application of Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623-30. doi:10.1016/S0140-6736(02)11600-
<div><p>Background</p><p>The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a pl...
Elderly patients represent a rising social problem, due to the exponential growth of persons in thes...
BACKGROUND: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-control...
A critical appraisal and clinical application of Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Sydney B Long, Michael J Blaha, Roger S Blumenthal, Erin D MichosJohns Hopkins Ciccarone Center for ...
Background: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderl...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of...
Background: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-control...
<div><p>Background</p><p>The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a pl...
Elderly patients represent a rising social problem, due to the exponential growth of persons in thes...
BACKGROUND: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-control...
A critical appraisal and clinical application of Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Sydney B Long, Michael J Blaha, Roger S Blumenthal, Erin D MichosJohns Hopkins Ciccarone Center for ...
Background: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderl...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of...
Background: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-control...
<div><p>Background</p><p>The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a pl...
Elderly patients represent a rising social problem, due to the exponential growth of persons in thes...
BACKGROUND: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-control...
DOI
Add to ORKG